Argatroban and Bivalirudin for Perioperative Anticoagulation in Cardiac Surgery Argatroban
and Bivalirudin for Perioperative Anticoagulation in Cardiac Surgery Anesthesiology. 2018 …

Thrombocytopenia as well as anti-platelet factor 4/heparin (PF4/H) antibodies are common
in cardiac surgery patients and those treated in the intensive care unit. In contrast, heparin …

Background: Anticoagulation is required during transcatheter aortic valve replacement
(TAVR) procedures. Although an optimal regimen has not been determined, heparin is …

Abstract Bivalirudin (Angiomax; The Medicines Company, Parsippany, NJ), a direct thrombin
inhibitor, has found increasing utilization as a heparin alternative in the pediatric population …

Objectives To determine the prognostic impact of anemia in patients randomized to
bivalirudin or unfractionated heparin (UFH) during transcatheter aortic valve replacement …

Background Bivalirudin may be an effective anticoagulation alternative to heparin as
anticoagulant agent in percutaneous transcatheter aortic valve interventions (PAVI). We …

Stroke in patients with valvular heart disease undergoing transcatheter intervention is
relatively rare but associated with significant morbidity and mortality. Risks vary according to …

In the paper the authors report the first in Russia clinical case of successful transcatheter
aortic valve implantation in high-risk patient with critical aortic stenosis and verified heparin …

Background Prior studies have suggested that patients with atrial fibrillation (AF) referred for
left atrial appendage occlusion (LAAO) are confronted with considerable risk of …

Авторы приводят первое в отечественной литературе описание клинического случая
успешной транскатетерной имплантации аортального клапана у пациента высокого …